Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2014 (2014), Article ID 285951, 9 pages
http://dx.doi.org/10.1155/2014/285951
Research Article

Contact Frequency, Travel Time, and Travel Costs for Patients with Rheumatoid Arthritis

1Centre for Applied Health Services Research, University of Southern Denmark, J.B. Winsløws Vej 9B, 5000 Odense, Denmark
2Center for Rheumatology and Spine Diseases, Glostrup Hospital, Denmark
3Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

Received 10 September 2013; Revised 23 December 2013; Accepted 24 December 2013; Published 17 February 2014

Academic Editor: Ronald F. van Vollenhoven

Copyright © 2014 Jan Sørensen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Gold, J. E. Siegel, L. B. Russel, and M. C. Weinstein, Eds., Cost-Effectiveness in Health and Medicine, Oxford University Press, New York, NY, USA, 1996.
  2. N. J. Cooper, M. Mugford, D. P. M. Symmons, E. M. Barrett, and D. G. I. Scott, “Development of resource-use and expenditure questionnaires for use in rheumatology research,” Journal of Rheumatology, vol. 30, no. 11, pp. 2485–2491, 2003. View at Google Scholar · View at Scopus
  3. S. Thomson, S. Wordsworth, and O. b. O. T. U. W. P. O. P. Costs, “An annotated cost questionnaire for completion by patients,” HERU Discussion Paper 03/01, University of Aberdeen, 2001. View at Google Scholar
  4. E. Moons et al., “Travel cost and time measurement,” in Travel Cost Models, Working Paper Series, Faculty of Economics and Applied Economic Studies, Katholieke Universiteit, Leuven, Belgium, 2001. View at Google Scholar
  5. C. Woolley, Z. Philips, D. K. Whynes et al., “United Kingdom cervical cancer screening and the costs of time and travel,” International Journal of Technology Assessment in Health Care, vol. 23, no. 2, pp. 232–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Frew, J. L. Wolstenholme, W. Atkin, and D. K. Whynes, “Estimating time and travel costs incurred in clinic based screening: flexible sigmoidoscopy screening for colorectal cancer,” Journal of Medical Screening, vol. 6, no. 3, pp. 119–123, 1999. View at Google Scholar · View at Scopus
  7. R. H. Seeker-Walker, P. M. Vacek, G. J. Hooper, D. A. Plante, and A. S. Detsky, “Screening for breast cancer: time, travel, and out-of-pocket expenses,” Journal of the National Cancer Institute, vol. 91, no. 8, pp. 702–708, 1999. View at Google Scholar · View at Scopus
  8. S. Bryan, M. Buxton, M. McKenna, H. Ashton, and A. Scott, “Private costs associated with abdominal aortic aneurysm screening: the importance of private travel and time costs,” Journal of Medical Screening, vol. 2, no. 2, pp. 62–66, 1995. View at Google Scholar · View at Scopus
  9. M. J. Sculpher, M. J. Buxton, B. A. Ferguson, D. J. Spiegelhalter, and A. J. Kirby, “Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies,” Health Economics, vol. 1, no. 1, pp. 39–51, 1992. View at Google Scholar · View at Scopus
  10. D. E. Jonas, B. Bryant Shilliday, W. R. Laundon, and M. Pignone, “Patient time requirements for anticoagulation therapy with warfarin,” Medical Decision Making, vol. 30, no. 2, pp. 206–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Jowett, S. Bryan, E. Murray et al., “Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis,” British Journal of Haematology, vol. 134, no. 6, pp. 632–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Parry, S. Bryan, K. Gee, E. Murray, and D. Fitzmaurice, “Patient costs in anticoagulation management: a comparison of primary and secondary care,” British Journal of General Practice, vol. 51, no. 473, pp. 972–976, 2001. View at Google Scholar · View at Scopus
  13. A. Bowling, K. Stramer, E. Dickinson, J. Windsor, and M. Bond, “Evaluation of specialists' outreach clinics in general practice in England: process and acceptability to patients, specialists, and general practitioners,” Journal of Epidemiology and Community Health, vol. 51, no. 1, pp. 52–61, 1997. View at Google Scholar · View at Scopus
  14. J. L. Hulsemann, T. Mittendorf, S. Merkesdal et al., “Direct costs related to rheumatoid arthritis: the patient perspective,” Annals of the Rheumatic Diseases, vol. 64, no. 10, pp. 1456–1461, 2005. View at Google Scholar
  15. L. Linde, J. Sørensen, M. Østergaard et al., “What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 health survey and the health assessment questionnaire?” Journal of Rheumatology, vol. 36, no. 10, pp. 2183–2189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Thorsen, T. M. Hansen, S. P. McKenna, S. F. Sørensen, and D. Whalley, “Adaptation into Danish of the stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality Of Life Scale (RAQoL),” Scandinavian Journal of Rheumatology, vol. 30, no. 2, pp. 103–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Williams, “EuroQol—a new facility for the measurement of health-related quality of life,” Health Policy, vol. 16, no. 3, pp. 199–208, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. K. U. Wittrup-Jensen, J. Lauridsen, C. Gudex, and K. M. Pedersen, “Generation of a Danish TTO value set for EQ-5D health states,” Scandinavian Journal of Public Health, vol. 37, no. 5, pp. 459–466, 2009. View at Publisher · View at Google Scholar · View at Scopus